Data linkage reduces loss to follow-up in an observational HIV cohort study

Journal of Clinical Epidemiology

Volumn 63, Issue 10, 2010, Pages 1101-1109

  Hill, Teresa ^a   Bansi, Loveleen ^a   Sabin, Caroline ^a   Phillips, Andrew ^a   Dunn, David ^b   Anderson, Jane ^c   Easterbrook, Philippa ^d   Fisher, Martin ^e   Gazzard, Brian ^f   Gilson, Richard ^a   Johnson, Margaret ^a   Leen, Clifford ^g   Orkin, Chloe ^h   Schwenk, Achim ⁱ   Walsh, John ^j   Winston, Alan ^j   Babiker, Abdel ^b   Delpech, Valerie ^k  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

^c HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^d KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^e UK   (United Kingdom)

^f CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^g NHS LOTHIAN   (United Kingdom)

^h BARTS HEALTH NHS TRUST   (United Kingdom)

ⁱ NORTH MIDDLESEX UNIVERSITY HOSPITAL NHS TRUST   (United Kingdom)

^j IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^k PUBLIC HEALTH ENGLAND   (United Kingdom)

more..

Author keywords

Cohort; Data linkage; Follow up; HIV; Loss to follow up; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DATA ANALYSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; PATIENT CARE; POISSON DISTRIBUTION; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM; CLINICAL TRIAL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEDICAL RECORD; MIDDLE AGED; MULTICENTER STUDY; PATIENT; RISK; STATISTICAL MODEL; STATISTICS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LOGISTIC MODELS; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; ODDS RATIO; PATIENT DROPOUTS; RISK FACTORS;

EID: 78349285180     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2009.12.007     Document Type: Article

References (13)

1. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JPfor the STROBE Initiative. The strengthening and reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344-9.
2. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-4.
3. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-94.
4. The UK Collaborative HIV Cohort Steering Committee. The creation of a largeUK-basedmulticentre cohort ofHIV-infected individuals: theUK CollaborativeHIV Cohort (UKCHIC) Study.HIVMed 2004;5:115-24.
5. Reekie J, Mocroft A, Sambatakou H, Machala L, Chiesi A, van Lunzen J, et alEuroSIDAStudy Group. Does less frequent routine monitoring of patients on a stable, fully suppressedcARTregimen lead to an increased risk of treatment failure? AIDS 2008;22:2381-90.
6. Arici C, Ripamonti D, Maggiolo F, Rizzi M, Finazzi MG, Pezzotti P, et al. Factors associated with the failure of HIV-positive persons to return for scheduled medical visits. HIV Clin Trials 2002;3:52-7.
7. Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, Chentsova N, et alfor the EuroSIDA Study Group. Loss to follow-up in an international, multicentre observational study. HIV Med 2008;9:261-9.
8. Prime K, Sethi G, Navaratne L, Dean G, Fox E, Sabin C, et al. Differences in presentation and follow-up between HIV-1 antibody positive teenagers and adults: the need for a more focused approach to care? AIDS 2003;17:260-2.
9. Lebouché B, Yazdanpanah Y, Gérard Y, Sissoko D, Ajana F, Alcaraz I, et al. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998. HIV Med 2006;7:140-5.
10. Lanoy E, Mary-Krause M, Tattevin P, Dray-Spira R, Duvivier C, Fischer P, et al. and the Clinical Epidemiology Group of the French Hospital Database on HIV infection. Predictors identified for losses to follow-up among HIV-seropositive patients. J Clin Epidemiol 2006;59:829-35.
11. Brettle RP, Willocks L, Hamilton BA, Shaw L, Leen CL, Richardson A, et al. Out-patient medical care in Edinburgh for IDU-related HIV. AIDS Care 1994;6:49-58.
12. Ioannidis JP, Bassett R, Hughes MD, Volberding PA, Sacks HS, Lau J. Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:22-30.
13. Porter K, Johhson AM, Phillips AN, Darbyshire JH. The practical significance of potential biases in estimates of the AIDS incubation period distribution in the UK Register of HIV Seroconverters. AIDS 1999;13:1943-51.